Bruker Corp. Stock
Bruker Corp. Stock
A loss of -1.600% shows a downward development for Bruker Corp..
Bruker Corp. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
With a target price of 46 € there is a slightly positive potential of 12.77% for Bruker Corp. compared to the current price of 40.79 €.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -1.600% | 0.123% | -2.904% | -26.451% | -26.451% | - | - |
| Integer Hldg | -0.760% | 0.763% | 7.317% | -48.031% | -48.031% | 3.937% | 1.538% |
| Omnicell Inc. | -0.510% | 1.563% | 25.000% | -6.250% | -6.250% | -13.333% | -58.511% |
| Healthequity Inc. | -0.640% | 0.000% | -11.798% | -13.736% | -13.736% | 38.938% | 40.179% |
Comments
Bruker (NASDAQ:BRKR) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its price target raised by analysts at Bank of America Corporation from $43.00 to $60.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $60.00 price target on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a